Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
- Status
- COMPLETED
- Phase
- N/A
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
- Status
- RECRUITING
- Phase
- N/A
Proteomics in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE1
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Immunological Variables Associated to ICI Toxicity in Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Mass Balance Study of [14C]Chiauranib
- Status
- COMPLETED
- Phase
- NA
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
- Status
- SUSPENDED
- Phase
- PHASE2
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2